ERBB3

Oncogene
Also known as LCCS2, HER3
ERBB3, a receptor tyrosine kinase, is altered by mutation or amplification in various cancer types.
Show ERBB3 background
NCBI Gene2065
Ensembl GeneENSG00000065361 (GRCh37/GRCh38)
Location
Chr12:56473641-56497289 (GRCh37)
Chr12:56076799-56103505 (GRCh38)
Ensembl TranscriptENST00000267101 (GRCh37/GRCh38)
RefSeqNM_001982.3 (GRCh37/GRCh38)
Annotated Mutations in MSK-IMPACT™ Clinical Sequencing Cohort (Zehir et al., Nat Med 2017)
A list of the oncogenic and mutation effects of all OncoKB™ curated ERBB3 alterations.
If you notice any mistakes or omissions, please reach out to us.
Alteration
Oncogenic
Mutation Effect
Description
Oncogenic
Gain-of-function
Likely Oncogenic
Likely Gain-of-function
Inconclusive
Inconclusive
Likely Oncogenic
Likely Gain-of-function
Oncogenic
Gain-of-function
Likely Oncogenic
Likely Gain-of-function
Likely Oncogenic
Likely Gain-of-function
Oncogenic
Gain-of-function
Oncogenic
Gain-of-function
Oncogenic
Gain-of-function
Likely Oncogenic
Likely Gain-of-function
Likely Oncogenic
Likely Gain-of-function
Likely Oncogenic
Likely Gain-of-function
Likely Neutral
Likely Neutral
Likely Oncogenic
Likely Gain-of-function
Oncogenic
Gain-of-function
Likely Oncogenic
Likely Gain-of-function
Inconclusive
Inconclusive
Likely Neutral
Likely Neutral
Oncogenic
Gain-of-function
Oncogenic
Gain-of-function
Oncogenic
Gain-of-function
Inconclusive
Inconclusive
Loading...